Accueil   Diary - News   All news Alizé Pharma to present results

Alizé Pharma to present results

ALIZE  NEWSLETTERAlizé Pharma announced that the results from its Phase II trial for AZP-531, its unacylated ghrelin analog, conducter in patients with Prader-Willi syndrome, will be presented at two upcoming scientific conference.

 


Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree